Condition: HR+/HER2- Early Breast Cancer · Sponsor: Institut fuer Frauengesundheit
The goal of this clinical trial is to evaluate the effect of patient education and patient typology-based coaching on therapy persistence in breast cancer patients taking ribociclib. Researchers will compare the time to permanent treatment discontinuation of patients receiving personalized coaching to the time to permanent treatment discontinuation of patients who only receive standard of care education and counselling, to see if adherence to treatment can be improved by personalized patient coaching.
This description comes directly from the study's public registry record.
Institut für Frauengesundheit GmbH · +49 9131 91880613 · typer@ifg-erlangen.de
Always discuss trial participation with your own doctor first.
| Department of Gynecology and Obstetrics, Universitätsklinikum Augsburg | Augsburg, Bavaria, Germany | Recruiting |
| Department of Obstetrics and Gynecology, Uniklinikum Erlangen | Erlangen, Bavaria, Germany | Recruiting |
| MVZ Klinikum Aschaffenburg, Zweigstelle Hänatologie und Onkologie | Hösbach, Bavaria, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07708571